FAR 2 Flashcards
Installment Sales
Delay profit recognition until cash is received
GP is recognized in income in proportion to the cash collection
Use when there is no reasonable basis to estimate the degree of collectibility (i.e. ultimate collectibility cannot be estimated)
Cost Recovery
Appropriate when there is doubt that amount due will be collected
IFRS Method for L/T construction contract
Cost Recovery Method and Percentage of completion
GAAP Method for L/T construction contract
Complete Method and Percentage of completion
Non-monetary Exchange
Treatment of gain with
Commercial Substance
Gain/loss recognize immediately
Gain = FV asset given up > BV asset given up
Loss =FV asset given up
Non-monetary Exchange
Treatment of gain with
Lack commercial Substance
- No boot received = no gain is recognized
- Boot is paid = no gain is recognized
[report at historical cost + cash] - Boot is received = recognize proportional gain (
Non-monetary exchanges
IFRS - dissimilar asset
Similar treatment to exchange with commercial substance
Exchange that generates revenue
All gain/loss recognized
Non-monetary exchanges
IFRS - similar asset
No gains are recognized
Exchange that generate revenue
Other Comprehensive Income
Include all changes in equity from non-owner transactions
Exclude investments by owners and distribution to owners
Other Comprehensive Income
PUFER
P - ension Cost U - unrealized gain/loss from avaible for sale securities F - foreign currency translation E - effective portion of net cash flows R - Revaluation gain (IFRS ONLY)
Presentation of OCI
May be shown on 1. statement of comprehensive income 2. in I/S under NI 3. statement of equity Must show tax effects
Comprehensive Income
Net Income + Other Comprehensive Income
Research and development cost
‘Expense’
- R&D performed by another company
- Equipment with no alternate use
- Testing for new products
- Laboratory research
- Depreciation expense of capitalized asset
- All costs related to unsuccessful defend of patent (e.g price, acquisition cost, legal cost)
Research and development cost
‘Capitalize’
- R&D to be reimbursed by third party
- Equipment, materials, facilities with alternate use
- All costs related to unsuccessful defend of patent (e.g price, acquisition cost, legal cost)
Involuntarily exchange
Loss = net book value + costs associated with the transaction
Gain/loss = proceed from sale - carrying amount of FA